The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program

Preventive Medicine

Volumn 77, Issue , 2015, Pages 125-130

  O'Brien, Matthew J ^a   Whitaker, Robert C ^b,c   Yu, Daohai ^c   Ackermann, Ronald T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes prevention; Educational attainment; Lifestyle intervention; Metformin; Socioeconomic status

Indexed keywords

GLUCOSE; METFORMIN; PLACEBO; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; CALORIC RESTRICTION; COMPARATIVE EFFECTIVENESS; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; GRADUATE; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; MALE; MULTICENTER STUDY (TOPIC); PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; UNITED STATES; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; EXERCISE; HEALTH PROMOTION; LIFESTYLE; MIDDLE AGED; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOCIAL CLASS; WEIGHT REDUCTION;

ADULT; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; EXERCISE; FEMALE; HEALTH PROMOTION; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; METFORMIN; MIDDLE AGED; RANDOM ALLOCATION; RISK REDUCTION BEHAVIOR; SOCIAL CLASS; UNITED STATES; WEIGHT LOSS;

EID: 84930635212     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.05.017     Document Type: Article

References (35)

1. Ackermann R.T., Marrero D.G. Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ. 2007, 33(1):69. (74-5, 7-8).
2. Adler N.E., Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. (Millwood) 2002, 21(2):60-76.
3. Adler N.E., Boyce T., Chesney M.A., et al. Socioeconomic status and health: the challenge of the gradient. Am. Psychol. 1994, 49(1):15.
4. Agardh E., Allebeck P., Hallqvist J., Moradi T., Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int. J. Epidemiol. 2011, 40(3):804-818.
5. Albright A.L., Gregg E.W. Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program. Am. J. Prev. Med. 2013, 44(4):S346-S351.
6. American Diabetes Association Economic costs of diabetes in the US in 2012. Diabetes Care 2013, 36(4):1033-1046.
7. Baquet C.R., Commiskey P., Mullins C.D., Mishra S.I. Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect. Prev. 2006, 30(1):24-33.
8. Black P.H. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav. Immun. 2003, 17(5):350-364.
9. Braveman P.A., Cubbin C., Egerter S., et al. Socioeconomic status in health research: one size does not fit all. JAMA 2005, 294(22):2879-2888.
10. Cavanaugh K., Huizinga M.M., Wallston K.A., et al. Association of numeracy and diabetes control. Ann. Intern. Med. 2008, 148(10):737-746.
11. Centers for Disease Control and Prevention (CDC) National diabetes fact sheet: national estimates and general Information on diabetes and prediabetes in the United States, 2011 2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
12. Centers for Disease Control and Prevention (CDC) Awareness of prediabetes-United States, 2005-2010. MMWR 2013, 62(11):209.
13. Chen P.C., Chan Y.T., Chen H.F., Ko M.C., Li C.Y. Population-based cohort analyses of the bidirectional relationship between type 2 diabetes and depression. Diabetes Care 2013, 36(2):376-382.
14. Diabetes Prevention Program Research Group The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999, 22(4):623.
15. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346(6):393-403.
16. Diabetes Prevention Program Research Group Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes. Res. 2004, 12(9):1426.
17. Diehl A.K., Bauer R.L., Sugarek N.J. Correlates of medication compliance in non-insulin-dependent diabetes mellitus. South. Med. J. 1987, 80(3):332-335.
18. Entwistle V.A., Watt I.S. Treating patients as persons: a capabilities approach to support delivery of person-centered care. Am. J. Bioeth. 2013, 13(8):29-39.
19. Ford J.G., Howerton M.W., Lai G.Y., et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 2008, 112(2):228-242.
20. Hamman R.F., Wing R.R., Edelstein S.L., et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006, 29(9):2102-2107.
21. Kao G., Thompson J.S. Racial and ethnic stratification in educational achievement and attainment. Annu. Rev. Sociol. 2003, 29:417-442.
22. Khatib R., Schwalm J.D., Yusuf S., et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS ONE 2014, 9(1):e84238.
23. Koenig C.J., Wingard L.M., Sabee C., Olsher D., Vandergriff I. Managing patient-centered communication across the type 2 diabetes illness trajectory: a grounded practical theory of interactional sensitivity. J. Appl. Commun. Res. 2014, 1-24. (ahead-of-print).
24. Kulkarni S.P., Alexander K.P., Lytle B., Heiss G., Peterson E.D. Long-term adherence with cardiovascular drug regimens. Am. Heart J. 2006, 151(1):185-191.
25. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 2002, 63(10):892-909.
26. Matthews K.A., Gallo L.C. Psychological perspectives on pathways linking socioeconomic status and physical health. Annu. Rev. Psychol. 2011, 62:501-530.
27. Pan X.R., Li G., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20(4):537-544.
28. Ross C.E., Wu C. The links between education and health. Am. Sociol. Rev. 1995, 60:719-745.
29. Street R.L., Makoul G., Arora N.K., Epstein R.M. How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Educ. Couns. 2009, 74:295-301.
30. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001, 344(18):1343-1350.
31. U.S.Census Bureau Census 2000 Brief: Educational Attainment 2003, U.S. Department of Commerce, Economics and Statistics Administration, Washington, D.C.
32. Vojta D., Koehler T.B., Longjohn M., Lever J.A., Caputo N.F. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am. J. Prev. Med. 2013, 44(4):S301-S306.
33. Waitzkin H. Information giving in medical care. J. Health Soc. Behav. 1985, 26:81-101.
34. Walker E.A., Molitch M., Kramer M.K., et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006, 29(9):1997-2002.
35. Wang R., Lagakos S.W., Ware J.H., Hunter D.J., Drazen J.M. Statistics in medicine-reporting of subgroup analyses in clinical trials. N. Engl. J. Med. 2007, 357(21):2189-2194.